Skip to main content
Flucelvax 15 ug/.5mL, 15 ug/.5mL, 15 ug/.5mL injection, suspension by Seqirus Inc.
Flucelvax, 15 ug/.5mL, 15 ug/.5mL, 15 ug/.5mL, injection, suspension Available on prescription only. Listed by Seqirus Inc..
Prescription only

Flucelvax

INFLUENZA A VIRUS A/Tasmania/318/2025 CVR-351 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Tasmania/787/2025 CVR-388 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Arizona/21/2025 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

Listed by Seqirus Inc.

Strength
15 ug/.5mL, 15 ug/.5mL, 15 ug/.5mL
Form
Injection, Suspension
Route
Intramuscular

What it contains

  • Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL
  • Influenza A Virus A/tasmania/787/2025 Cvr-388 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL
  • Influenza B Virus - B/arizona/21/2025 Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL

This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.

FDA record

Dosage form Injection, Suspension
Route Intramuscular
Approval route BLA — biologic licence
NDC code 70461-656
FDA application BLA125408
Package sizes listed 1
Marketed since July 2026

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.